K. Kinzler and B. Vogelstein, Lessons from Hereditary Colorectal Cancer, Cell, vol.87, issue.2, pp.159-170, 1996.
DOI : 10.1016/S0092-8674(00)81333-1

URL : http://doi.org/10.1016/s0092-8674(00)81333-1

O. Galamb, F. Sipos, K. Fischer, Z. Tulassay, and B. Molnar, The results of the expression array studies correlate and enhance the known genetic basis of gastric and colorectal cancer, Cytometry Part B: Clinical Cytometry, vol.81, issue.1, pp.1-17, 2005.
DOI : 10.1002/cyto.b.20069

R. Goldberg, D. Sargent, R. Morton, C. Fuchs, R. Ramanathan et al., A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.22, issue.1, pp.23-30, 2004.
DOI : 10.1200/JCO.2004.09.046

P. Jandik, T. Iveson, J. Carmichael, M. Alakl, G. Gruia et al., Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial, Lancet, vol.355, pp.1041-1048, 2000.

H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth et al., Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer, New England Journal of Medicine, vol.350, issue.23, pp.2335-2377, 2004.
DOI : 10.1056/NEJMoa032691

D. Cunningham, Y. Humblet, S. Siena, D. Khayat, H. Bleiberg et al., Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer, New England Journal of Medicine, vol.351, issue.4, pp.337-382, 2004.
DOI : 10.1056/NEJMoa033025

H. Zhang, Y. Gu, Z. Li, Y. Jia, L. Yuan et al., Exposure of Human Lung Cancer Cells to 8-Chloro-Adenosine Induces G2/M Arrest and Mitotic Catastrophe, Neoplasia, vol.6, issue.6, pp.802-814, 2004.
DOI : 10.1593/neo.04247

T. De-koning, K. Snell, M. Duran, R. Berger, B. Poll-the et al., l-Serine in disease and development, Biochemical Journal, vol.371, issue.3, pp.653-61, 2003.
DOI : 10.1042/bj20021785

J. Paredes and L. Guijarro, Reviewing the mechanism of action of thiopurine drugs: towards a new paradigm in clinical practice, Med Sci Monit, vol.10, pp.247-54, 2004.

H. Eagle, Amino Acid Metabolism in Mammalian Cell Cultures, Science, vol.130, issue.3373, pp.432-439, 1959.
DOI : 10.1126/science.130.3373.432

M. Maxwell, T. Mccoy, and R. Neuman, The amino acid requirements of the walker carcinosarcoma 256 in vitro, Cancer Res, vol.16, pp.979-84, 1956.

K. Snell, Y. Natsumeda, J. Eble, J. Glover, and G. Weber, Enzymic imbalance in serine metabolism in human colon carcinoma and rat sarcoma, British Journal of Cancer, vol.57, issue.1, pp.87-90, 1988.
DOI : 10.1038/bjc.1988.15

D. Rio, M. Molina, F. Bascoul-mollevi, C. Copois, V. Bibeau et al., Gene Expression Signature for the Prediction of Response to Leucovorin, Fluorouracil, and Irinotecan in Advanced Colorectal Cancer Patients, J Clin Oncol, vol.25, pp.773-780, 2007.

P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. Mcmahon et al., New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening, JNCI Journal of the National Cancer Institute, vol.82, issue.13, pp.1107-1119, 1990.
DOI : 10.1093/jnci/82.13.1107